BRIEF-Alnylam presents updated results from phase 1/2 study of ALN-CC5 in patients with paroxysmal nocturnal hemoglobinuria
December 05, 2016 at 13:11 PM EST
* Alnylam presents updated results from phase 1/2 study of aln-cc5 in patients with paroxysmal nocturnal hemoglobinuria (pnh)